AIM
Price
$2.48
Change
+$0.04 (+1.64%)
Updated
Sep 5 closing price
Capitalization
6.72M
RLYB
Price
$0.61
Change
+$0.02 (+3.39%)
Updated
Sep 5 closing price
Capitalization
25.43M
60 days until earnings call
Interact to see
Advertisement

AIM vs RLYB

Header iconAIM vs RLYB Comparison
Open Charts AIM vs RLYBBanner chart's image
AIM ImmunoTech
Price$2.48
Change+$0.04 (+1.64%)
Volume$51.6K
Capitalization6.72M
Rallybio
Price$0.61
Change+$0.02 (+3.39%)
Volume$294.39K
Capitalization25.43M
AIM vs RLYB Comparison Chart in %
Loading...
AIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AIM vs. RLYB commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIM is a Hold and RLYB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (AIM: $2.48 vs. RLYB: $0.61)
Brand notoriety: AIM and RLYB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AIM: 24% vs. RLYB: 21%
Market capitalization -- AIM: $6.72M vs. RLYB: $25.43M
AIM [@Biotechnology] is valued at $6.72M. RLYB’s [@Biotechnology] market capitalization is $25.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIM’s FA Score shows that 1 FA rating(s) are green whileRLYB’s FA Score has 1 green FA rating(s).

  • AIM’s FA Score: 1 green, 4 red.
  • RLYB’s FA Score: 1 green, 4 red.
According to our system of comparison, RLYB is a better buy in the long-term than AIM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIM’s TA Score shows that 4 TA indicator(s) are bullish while RLYB’s TA Score has 4 bullish TA indicator(s).

  • AIM’s TA Score: 4 bullish, 3 bearish.
  • RLYB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AIM is a better buy in the short-term than RLYB.

Price Growth

AIM (@Biotechnology) experienced а +1.22% price change this week, while RLYB (@Biotechnology) price change was +13.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

RLYB is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLYB($25.4M) has a higher market cap than AIM($6.72M). RLYB YTD gains are higher at: -36.604 vs. AIM (-87.475). AIM has higher annual earnings (EBITDA): -15.32M vs. RLYB (-43.29M). RLYB has more cash in the bank: 45.7M vs. AIM (835K). RLYB has less debt than AIM: RLYB (58K) vs AIM (2.81M). RLYB has higher revenues than AIM: RLYB (761K) vs AIM (121K).
AIMRLYBAIM / RLYB
Capitalization6.72M25.4M26%
EBITDA-15.32M-43.29M35%
Gain YTD-87.475-36.604239%
P/E RatioN/AN/A-
Revenue121K761K16%
Total Cash835K45.7M2%
Total Debt2.81M58K4,836%
FUNDAMENTALS RATINGS
AIM: Fundamental Ratings
AIM
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AIMRLYB
RSI
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 17 days ago
77%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
AIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IONR3.920.57
+17.08%
ioneer Ltd
GLW71.191.47
+2.11%
Corning
SLGN45.170.32
+0.71%
Silgan Holdings
UDMY6.68-0.03
-0.45%
Udemy
TOPS5.43-0.03
-0.57%
TOP Ships

RLYB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLYB has been loosely correlated with PROK. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RLYB jumps, then PROK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLYB
1D Price
Change %
RLYB100%
+3.86%
PROK - RLYB
45%
Loosely correlated
-2.17%
PXXLF - RLYB
44%
Loosely correlated
N/A
ATXS - RLYB
38%
Loosely correlated
+7.43%
PRME - RLYB
37%
Loosely correlated
+9.41%
SEOVF - RLYB
34%
Loosely correlated
+3.89%
More